Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

EBS Emergent BioSolutions

20.990
+0.210+1.01%
Close 09/30 16:00 ET
20.9900.0000.00%
Post Mkt Price 09/30 16:07 ET
High
21.880
Open
20.890
Turnover
11.04M
Low
20.890
Pre Close
20.780
Volume
519.48K
Market Cap
1.05B
P/E(TTM)
12.27
52wk High
55.210
Shares
49.86M
P/E(Static)
4.92
52wk Low
20.060
Float Cap
948.95M
Bid/Ask %
-60.00%
Historical High
137.610
Shs Float
45.21M
Volume Ratio
0.91
Historical Low
4.400
Dividend TTM
--
Div Yield TTM
--
P/B
0.69
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.15%
Amplitude
4.76%
Avg Price
21.249
Lot Size
1
Float Cap
948.95M
Bid/Ask %
-60.00%
Historical High
137.610
Shs Float
45.21M
Volume Ratio
0.91
Historical Low
4.400
Dividend TTM
--
P/B
0.69
Dividend LFY
--
Turnover Ratio
1.15%
Amplitude
4.76%
Avg Price
21.249
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.
CEO: Mr. Robert G. Kramer, Sr
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...